Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT06736769
PHASE2

Ketamine Effects on Learning In Eating Disorders

Sponsor: Amanda Downey, MD

View on ClinicalTrials.gov

Summary

This is a single site, single dose clinical trial of intravenous (IV) ketamine for medically hospitalized adolescents and young adults with anorexia nervosa or atypical anorexia nervosa. Eating disorder symptoms will be measured pre- and post-ketamine infusion. Investigators hypothesize that ketamine will increase cognitive flexibility, making medical hospitalizations less distressing by improving the ability to learn new, positive associations with food.

Official title: "KETTLE" Trial: Ketamine Effects on Learning In Eating Disorders

Key Details

Gender

All

Age Range

16 Years - 26 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2025-06-05

Completion Date

2026-06

Last Updated

2025-06-10

Healthy Volunteers

No

Interventions

DRUG

Ketamine infusion

Ketamine will be delivered intravenously at 0.5 mg/kg over 40 minutes.

Locations (1)

University of California, San Francisco

San Francisco, California, United States